Dysregulation of the Peroxisome Proliferator-Activated Receptor Target Genes by XPD Mutations

REFERENCES

• Adams, M., M. J. Reginato, D. Shao, M. A. Lazar, and V. K. Chatterjee. 1997. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272:5128–5132.
   PubMed Web of Science ®Google Scholar
• Akoulitchev, S., S. Chuikov, and D. Reinberg. 2000. TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407:102–106.
   PubMed Web of Science ®Google Scholar
• Auwerx, J. 1999. PPARγ, the ultimate thrifty gene. Diabetologia 42:1033–1049.
   PubMed Web of Science ®Google Scholar
• Berger, J., and D. E. Moller. 2002. The mechanisms of action of PPARs. Annu. Rev. Med. 53:409–435.
   PubMed Web of Science ®Google Scholar
• Bootsma, D., and J. H. J. Hoeijmakers. 1993. DNA repair. Engagement with transcription. Nature 363:114–115.
   PubMed Web of Science ®Google Scholar
• Botta, E., T. Nardo, B. C. Broughton, S. Marinoni, A. R. Lehmann, and M. Stefanini. 1998. Analysis of mutations in the XPD gene in Italian patients with trichothiodystrophy: site of mutation correlates with repair deficiency, but gene dosage appears to determine clinical severity. Am. J. Hum. Genet. 63:1036–1048.
   PubMedGoogle Scholar
• Chen, D., T. Riedl, E. Washbrook, P. E. Pace, R. C. Coombes, J. M. Egly, and S. Ali. 2000. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 6:127–137.
   PubMed Web of Science ®Google Scholar
• Cherkaoui-Malki, M., K. Meyer, W. Q. Cao, N. Latruffe, A. V. Yeldandi, M. S. Rao, C. A. Bradfield, and J. K. Reddy. 2001. Identification of novel peroxisome proliferator-activated receptor alpha (PPARα) target genes in mouse liver using cDNA microarray analysis. Gene. Expr. 9:291–304.
   PubMed Web of Science ®Google Scholar
• Coin, F., J. C. Marinoni, C. Rodolfo, S. Fribourg, A. M. Pedrini, and J. M. Egly. 1998. Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH. Nat. Genet. 20:184–188.
   PubMed Web of Science ®Google Scholar
• de Boer, J., J. de Wit, H. van Steeg, R. J. Berg, H. Morreau, P. Visser, A. R. Lehmann, M. Duran, J. H. Hoeijmakers, and G. Weeda. 1998. A mouse model for the basal transcription/DNA repair syndrome trichothiodystrophy. Mol. Cell 1:981–990.
   PubMedGoogle Scholar
• Desvergne, B., and W. Wahli. 1999. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:649–688.
   PubMed Web of Science ®Google Scholar
• Drane, P., E. Compe, P. Catez, P. Chymkowitch, and J. M. Egly. 2004. Selective regulation of vitamin D receptor-responsive genes by TFIIH. Mol. Cell 16:187–197.
   PubMed Web of Science ®Google Scholar
• Dubaele, S., L. Proietti De Santis, R. Bienstock, A. Keriel, M. Stefanini, B. Van Houten, and J. Egly. 2003. Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Mol. Cell 11:1635–1646.
   PubMed Web of Science ®Google Scholar
• Grosschedl, R. 1995. Higher-order nucleoprotein complexes in transcription: analogies with site-specific recombination. Curr. Opin. Cell Biol. 7:362–370.
   PubMedGoogle Scholar
• Happle, R., H. Traupe, H. Grobe, and G. Bonsmann. 1984. The Tay syndrome (congenital ichthyosis with trichothiodystrophy). Eur. J. Pediatr. 141:147–152.
   PubMedGoogle Scholar
• He, W., Y. Barak, A. Hevener, P. Olson, D. Liao, J. Le, M. Nelson, E. Ong, J. M. Olefsky, and R. M. Evans. 2003. Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. USA 100:15712–15717.
   PubMed Web of Science ®Google Scholar
• Hengartner, C. J., V. E. Myer, S. M. Liao, C. J. Wilson, S. S. Koh, and R. A. Young. 1998. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol. Cell 2:43–53.
   PubMed Web of Science ®Google Scholar
• Holstege, F. C., P. C. van der Vliet, and H. T. Timmers. 1996. Opening of an RNA polymerase II promoter occurs in two distinct steps and requires the basal transcription factors IIE and IIH. EMBO J. 15:1666–1677.
   PubMedGoogle Scholar
• Hu, E., J. B. Kim, P. Sarraf, and B. M. Spiegelman. 1996. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ. Science 274:2100–2103.
   PubMed Web of Science ®Google Scholar
• Humbert, S., H. van Vuuren, Y. Lutz, J. H. J. Hoeijmakers, J. M. Egly, and V. Moncollin. 1994. p44 and p34 subunits of the BTF2/TFIIH transcription factor have homologies with SSL, a yeast protein involved in DNA repair. EMBO J. 13:2393–2398.
   PubMedGoogle Scholar
• Itin, P. H., and M. R. Pittelkow. 1990. Trichothiodystrophy: review of sulfur-deficient brittle hair syndromes and association with the ectodermal dysplasias. J. Am. Acad. Dermatol. 22:705–717.
   PubMedGoogle Scholar
• Johnson, R. T., S. Squires, G. C. Ellion, G. L. E. Koch, and A. J. Rainbow. 1985. Xeroderma pigmentosum D-HeLa hybrids with low and high ultraviolet sensitivity associated with normal and diminished DNA repair ability, respectively. J. Cell Sci. 76:115–133.
   PubMedGoogle Scholar
• Juge-Aubry, C. E., E. Hammar, C. Siegrist-Kaiser, A. Pernin, A. Takeshita, W. W. Chin, A. G. Burger, and C. A. Meier. 1999. Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain. J. Biol. Chem. 274:10505–10510.
   PubMed Web of Science ®Google Scholar
• Kato, S., H. Endoh, Y. Masuhiro, T. Kitamoto, S. Uchiyama, H. Sasaki, S. Masushige, Y. Gotoh, E. Nishida, H. Kawashima, et al. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491–1494.
   PubMed Web of Science ®Google Scholar
• Keriel, A., A. Stary, A. Sarasin, C. Rochette-Egly, and J. M. Egly. 2002. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARα. Cell 109:125–135.
   PubMedGoogle Scholar
• Kersten, S., B. Desvergne, and W. Wahli. 2000. Roles of PPARs in health and disease. Nature 405:421–424.
   PubMed Web of Science ®Google Scholar
• Kopecky, J., Z. Hodny, M. Rossmeisl, I. Syrovy, and L. P. Kozak. 1996. Reduction of dietary obesity in aP2-Ucp transgenic mice: physiology and adipose tissue distribution. Am. J. Physiol. 270:E768–E775.
   PubMedGoogle Scholar
• Lee, C. H., P. Olson, and R. M. Evans. 2003. Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144:2201–2207.
   PubMed Web of Science ®Google Scholar
• Lehmann, A. R. 2001. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes Dev. 15:15–23.
   PubMed Web of Science ®Google Scholar
• Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPARγ). J. Biol. Chem. 270:12953–12956.
   PubMed Web of Science ®Google Scholar
• Lemon, B. D., J. D. Fondell, and L. P. Freedman. 1997. Retinoid X receptor:vitamin D3 receptor heterodimers promote stable preinitiation complex formation and direct 1,25-dihydroxyvitamin D3-dependent cell-free transcription. Mol. Cell. Biol. 17:1923–1937.
   PubMedGoogle Scholar
• Lu, H., L. Zawel, L. Fisher, J. M. Egly, and D. Reinberg. 1992. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature 358:641–645.
   PubMed Web of Science ®Google Scholar
• Mascaro, C., E. Acosta, J. A. Ortiz, P. F. Marrero, F. G. Hegardt, and D. Haro. 1998. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J. Biol. Chem. 273:8560–8563.
   PubMed Web of Science ®Google Scholar
• Moitra, J., M. M. Mason, M. Olive, D. Krylov, O. Gavrilova, B. Marcus-Samuels, L. Feigenbaum, E. Lee, T. Aoyama, M. Eckhaus, M. L. Reitman, and C. Vinson. 1998. Life without white fat: a transgenic mouse. Genes Dev. 12:3168–3181.
   PubMed Web of Science ®Google Scholar
• Reddy, J. K., and T. Hashimoto. 2001. Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 21:193–230.
   PubMed Web of Science ®Google Scholar
• Rickert, P., J. L. Corden, and E. Lees. 1999. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 18:1093–1102.
   PubMed Web of Science ®Google Scholar
• Riedl, T., F. Hanaoka, and J. Egly. 2003. The comings and goings of nucleotide excision repair factors on damaged DNA. EMBO J. 22:5293–5303.
   PubMed Web of Science ®Google Scholar
• Rochette-Egly, C., S. Adam, M. Rossignol, J. M. Egly, and P. Chambon. 1997. Stimulation of RARα activation function AF-1 through binding to the general transcription factor TFIIH and phosphorylation by CDK7. Cell 90:97–107.
   PubMed Web of Science ®Google Scholar
• Rosen, E. D., P. Sarraf, A. E. Troy, G. Bradwin, K. Moore, D. S. Milstone, B. M. Spiegelman, and R. M. Mortensen. 1999. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4:611–617.
   PubMed Web of Science ®Google Scholar
• Roy, R., J. P. Adamczewski, T. Seroz, W. Vermeulen, J. P. Tassan, L. Schaeffer, J. H. J. Hoeijmakers, and J. M. Egly. 1994. The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor. Cell 79:1093–1101.
   PubMed Web of Science ®Google Scholar
• Sandrock, B., and J. M. Egly. 2001. A yeast four-hybrid system identifies Cdk-activating kinase as a regulator of the XPD helicase, a subunit of transcription factor IIH. J. Biol. Chem. 276:35328–35333.
   PubMedGoogle Scholar
• Sears, I. B., M. A. MacGinnitie, L. G. Kovacs, and R. A. Graves. 1996. Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma. Mol. Cell. Biol. 16:3410–3419.
   PubMed Web of Science ®Google Scholar
• Shimomura, I., R. E. Hammer, J. A. Richardson, S. Ikemoto, Y. Bashmakov, J. L. Goldstein, and M. S. Brown. 1998. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12:3182–3194.
   PubMed Web of Science ®Google Scholar
• Taylor, E. M., B. C. Broughton, E. Botta, M. Stefanini, A. Sarasin, N. G. Jaspers, H. Fawcett, S. A. Harcourt, C. F. Arlett, and A. R. Lehmann. 1997. Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc. Natl. Acad. Sci. USA 94:8658–8663.
   PubMed Web of Science ®Google Scholar
• Tirode, F., D. Busso, F. Coin, and J. M. Egly. 1999. Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7. Mol. Cell 3:87–95.
   PubMed Web of Science ®Google Scholar
• Tontonoz, P., E. Hu, and B. M. Spiegelman. 1994. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79:1147–1156.
   PubMed Web of Science ®Google Scholar
• van Steeg, H., and K. H. Kraemer. 1999. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol. Med. Today 5:86–94.
   PubMedGoogle Scholar
• Wang, Y. X., C. H. Lee, S. Tiep, R. T. Yu, J. Ham, H. Kang, and R. M. Evans. 2003. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113:159–170.
   PubMed Web of Science ®Google Scholar
• Zurita, M., and C. Merino. 2003. The transcriptional complexity of the TFIIH complex. Trends Genet. 19:578–584.
   PubMed Web of Science ®Google Scholar